Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A D'Alessio

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Cell|January 13, 2010
Shifting players and paradigms in cell-specific transcriptionJoseph A D'Alessio, Kevin J Wright, Robert Tjian
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Core promoter recognition complex changes accompany liver developmentJoseph A D'Alessio, Raymond Ng, Holger Willenbring, et al.
Developmental Biology|August 9, 2005
Pax3/7 genes reveal conservation and divergence in the arthropod segmentation hierarchyGregory K Davis, Joseph A D'Alessio, Nipam H Patel
Genes & Development|January 20, 2007
IRES-mediated functional coupling of transcription and translation amplifies insulin receptor feedbackMichael T Marr, Joseph A D'Alessio, Oscar Puig, et al.
Molecular Biology of the Cell|November 14, 2002
Motility determinants in WASP family proteinsDefne Yarar, Joseph A D'Alessio, Robert L Jeng, et al.
Science (New York, N.Y.)|October 21, 2006
Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASP-like proteinErin D Goley, Taro Ohkawa, Joel Mancuso, et al.
Plos One|April 21, 2015
Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophoresSindy Liao-Chan, Barbara Daine-Matsuoka, Nathan Heald, et al.
Cellular Microbiology|July 9, 2004
A Rickettsia WASP-like protein activates the Arp2/3 complex and mediates actin-based motilityRobert L Jeng, Erin D Goley, Joseph A D'Alessio, et al.
Molecular Cancer Therapeutics|February 8, 2022
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid TumorsMatteo Duca, Darren Wan-Teck Lim, Vivek Subbiah, et al.
Cancer Immunology Research|November 12, 2020
A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody TherapySi-Qi Liu, Alyssa Grantham, Casey Landry, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Cell|January 13, 2010
Shifting players and paradigms in cell-specific transcriptionJoseph A D'Alessio, Kevin J Wright, Robert Tjian
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Core promoter recognition complex changes accompany liver developmentJoseph A D'Alessio, Raymond Ng, Holger Willenbring, et al.
Developmental Biology|August 9, 2005
Pax3/7 genes reveal conservation and divergence in the arthropod segmentation hierarchyGregory K Davis, Joseph A D'Alessio, Nipam H Patel
Genes & Development|January 20, 2007
IRES-mediated functional coupling of transcription and translation amplifies insulin receptor feedbackMichael T Marr, Joseph A D'Alessio, Oscar Puig, et al.
Molecular Biology of the Cell|November 14, 2002
Motility determinants in WASP family proteinsDefne Yarar, Joseph A D'Alessio, Robert L Jeng, et al.
Science (New York, N.Y.)|October 21, 2006
Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASP-like proteinErin D Goley, Taro Ohkawa, Joel Mancuso, et al.
Plos One|April 21, 2015
Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophoresSindy Liao-Chan, Barbara Daine-Matsuoka, Nathan Heald, et al.
Cellular Microbiology|July 9, 2004
A Rickettsia WASP-like protein activates the Arp2/3 complex and mediates actin-based motilityRobert L Jeng, Erin D Goley, Joseph A D'Alessio, et al.
Molecular Cancer Therapeutics|February 8, 2022
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid TumorsMatteo Duca, Darren Wan-Teck Lim, Vivek Subbiah, et al.
Cancer Immunology Research|November 12, 2020
A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody TherapySi-Qi Liu, Alyssa Grantham, Casey Landry, et al.
Pageof 2